T2 Biosystems Receives $10,800,000 Series B Round

  • Feed Type
  • Date
    10/17/2008
  • Company Name
    T2 Biosystems
  • Mailing Address
    286 Cardinal Medeiros Avenue Cambridge, MA 02141
  • Company Description
    T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care.
  • Website
    http://www.t2biosystems.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,800,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to accelerate the development of T2 Biosystems’ revolutionary rapid diagnostic platform.
  • M&A Terms
  • Venture Investor
    In-Q-Tel
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Flybridge Capital Partners

By posting a comment, you agree to our terms and conditions.